相关实验视频
Updated: May 8, 2025
04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
147
抗肥胖的第一个三重激动剂:Retatrutide
Lauren Tetelbaun1, Jamie A Mullally2, William H Frishman1,2
1From the School of Medicine, New York Medical College, Valhalla, NY.
Cardiology in review
|December 26, 2024
概括
雷塔胺是一种新型的三重激动剂,在治疗肥胖的临床试验中显示出优异的减肥效果. 这种新药在管理超重和肥胖方面具有显著的潜力,超出了传统的生活方式的改变.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 超重和肥胖的全球流行率不断上升,需要先进的治疗策略.
- 目前的生活方式的修改导致体重减轻有限 (3-5%),不足以显著改善健康.
- 药物治疗对于实现显著的减肥 (5-15%) 和管理肥胖相关疾病至关重要.
研究的目的:
- 评估三重激动剂 - - 雷达特的有效性和安全性,用于超重和肥胖个体的减肥.
- 评估retatrutide的药理学概况和耐受性.
- 为了在临床试验中比较雷达胺的减肥结果与安慰剂.
主要方法:
- 进行了1期和2期临床试验,以评估复原.
- 在患有肥胖和/或2型糖尿病的患者中,评估了药理动力学,安全性,耐受性和减肥疗效.
- 雷塔丁向葡萄糖类-1受体 (GLP-1R),依赖葡萄糖的胰岛素型多受体和葡萄糖受体.
主要成果:
- 雷塔鲁提德证明了与剂量成比例的药理动力学,平均半衰期约为6天,支持每周服用一次剂量.
- 安全性概况与现有的GLP-1R激动剂相当,胃肠道疾病是最常见的不良反应.
- 与安慰剂相比,与雷达特类药物观察到显著和优异的体重减轻,较高剂量显示出更大的疗效.
结论:
- 雷塔胺作为超重和肥胖患者的减肥药物表现出卓越的疗效.
- 该药物的安全性和耐受性概况对辅助肥胖治疗有希望.
- 雷塔胺代表了体重管理药物治疗的重大进步.
相关概念视频
01:24Glucagon-like Receptor Agonists
250
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
250
01:17Drugs for Treatment of Diarrhea-Predominant IBS
117
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
117
01:23Antidepressant Drugs: MAOIs and Other Agents
159
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
159
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
172
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
172
01:21Drugs for Treatment of Constipation-Predominant IBS
109
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
109
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
221
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
221